American journal of respiratory and critical care medicine
-
Am. J. Respir. Crit. Care Med. · Oct 1995
Comparative StudyAlbuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency.
Using an in vitro model, we compared efficiencies of jet nebulizers and metered-dose inhalers (MDI) with actuator devices to deliver albuterol in various conditions of mechanical ventilation. Factors tested included influence of humidification, MDI actuator device (Aerovent spacer or Marquest 172275 MDI adaptor), and synchronization of MDI to the respiratory cycle. With the nebulizer (AeroTech II) filled with 2.5 mg albuterol sulfate in 3 ml water and run until dry, inhaled mass was 42 +/- 2.6% and mass median aerodynamic diameter (MMAD) was 1.3 microns on a nonhumidified circuit. ⋯ All other MDI actuations led to essentially biphasic distributions, with particles greater than 1 micron following a distribution similar to the nebulizer and the overall MMAD estimated to be 0.22 microns. The AeroTech II delivered a cumulative 1,000 micrograms of drug (2,500 x 0.40) over 40 min. To achieve that amount, the MDI connected to the Aerovent and used in its most efficient sequence would require 45 timed puffs (90 micrograms per puff, 25.1% mean inhaled mass) and take 45 min of an experienced therapist's time.(ABSTRACT TRUNCATED AT 250 WORDS)
-
Am. J. Respir. Crit. Care Med. · Sep 1995
Tidal volume maintenance during weaning with pressure support.
Ventilation was measured in 31 difficult-to-wean patients while pressure support (PS) was reduced by 5 cm H2O every 20 min. Weaning had to be aborted in 14 of 31 patients (Group F) because they met predefined distress criteria. The remaining 17 patients who were able to complete the "weaning test" (Group S) had larger static respiratory compliances (Cstat = 0.08 +/- 0.02 versus 0.05 +/- 0.01 L/cm H2O, p < or = 0.05) and a lower dead space to tidal volume ratio (0.55 +/- 0.05 versus 0.64 +/- 0.06, p < or = 0.05). ⋯ In contrast, Group F patients defended VT at higher PS settings but were unable to maintain VT during distress. Ventilatory response parameters such as the rapid shallow breathing index were of limited value in predicting weaning outcome and yielded receiver operator curve area values between 0.66 and 0.82 over the range of PS settings tested. We conclude that the gradual withdrawal of machine support does not facilitate the recognition of impending respiratory failure.
-
Am. J. Respir. Crit. Care Med. · Sep 1995
Randomized Controlled Trial Clinical TrialPostoperative physical therapy after coronary artery bypass surgery.
Coronary artery bypass surgery is frequently complicated by postoperative atelectasis. Although routinely prescribed, the efficacy of any specific chest physical therapy is not well established. We studied patients at a university center undergoing elective coronary artery bypass surgery. ⋯ We conclude that postoperative respiratory dysfunction is common but does not commonly cause significant morbidity or prolong hospital stay. Adding SMI to patients with minimal atelectasis at extubation does not improve clinical outcomes. Similarly, adding SSP to patients with marked atelectasis does not improve outcomes over those obtained with SMI and early ambulation.
-
Am. J. Respir. Crit. Care Med. · Sep 1995
Incidence of the adult respiratory distress syndrome in the state of Utah.
To determine the incidence of the adult respiratory distress syndrome (ARDS) in Utah, we prospectively screened intensive-care-unit (ICU) patients for ARDS in six of the 40 general acute-care hospitals in Utah. Over a 1-yr period, we diagnosed severe ARDS (oxygenation criterion: PaO2/PAO2 < or = 0.2) in 110 patients. Of these patients, 27 were not residents of Utah. ⋯ Incorporating these two estimates, we calculated an estimated upper limit for ARDS incidence in Utah of 8.3 ARDS patients per 100,000 total Utah population per year. Using only directly identified Utah residents with ARDS, we calculated the absolute lower limit for ARDS incidence in Utah to be 4.8 ARDS patients per 100,000 Utah population per year. The incidence of ARDS in Utah is about an order of magnitude less than the 1972 National Heart and Lung Institute Task Force estimate of ARDS incidence in the United States, but agrees with more recently published ARDS incidence figures.